about
The caudal medullary ventrolateral reticular formation in nociceptive-cardiovascular integration. An experimental study in the rat.Hypertension due to blockade of adenosine receptors.Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR ratsAspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs.Statins and oxidative stress in chronic heart failure.Longer duration of obesity is associated with a reduction in urinary angiotensinogen in prepubertal children.Does chronic pain alter the normal interaction between cardiovascular and pain regulatory systems? Pain modulation in the hypertensive-monoarthritic rat.Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity.Association of myeloperoxidase levels with cardiometabolic factors and renal function in prepubertal children.Effects of sympathetic denervation on liver fibroblasts: prevention by adenosine.Urinary fibrogenic cytokines ET-1 and TGF-β1 are associated with urinary angiotensinogen levels in obese children.Gender and obesity modify the impact of salt intake on blood pressure in children.Hypertension due to chronic blockade of P1-purinoceptors.Morphine glucuronidation increases its analgesic effect in guinea pigs.Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors.The hyperalgesic effects induced by the injection of angiotensin II into the caudal ventrolateral medulla are mediated by the pontine A5 noradrenergic cell group.Superoxide dismutase partially prevents sympathetic denervation by 6-hydroxydopamine.Xanthine oxidase inhibition by 1,3-dipropyl-8-sulfophenylxanthine (DPSPX), an antagonist of adenosine receptors.A pharmacological differentiation between postjunctional (AT1A) and prejunctional (AT1B) angiotensin II receptors in the rabbit aorta.Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia.Scavenging of nitric oxide by an antagonist of adenosine receptors.Oxidative stress and nitric oxide are increased in obese children and correlate with cardiometabolic risk and renal function.Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors.Diabetes-induced increase of renal medullary hydrogen peroxide and urinary angiotensinogen is similar in normotensive and hypertensive rats.Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade.Inhibition of nociceptive responses of spinal cord neurones during hypertension involves the spinal GABAergic system and a pain modulatory center located at the caudal ventrolateral medulla.Lesion of the caudal ventrolateral medulla prevents the induction of hypertension by adenosine receptor blockade in rats.Decrease in the expression of N-methyl-D-aspartate receptors in the nucleus tractus solitarii induces antinociception and increases blood pressure.Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events.Hypertension inhibits noxious-evoked c-fos expression in the rat spinal cordSympathetic denervation causes atrial natriuretic peptide-storing granules to appear in the ventricular myocardium of the ratl-proline supplementation improves nitric oxide bioavailability and counteracts the blood pressure rise induced by angiotensin II in ratsImpaired resolution of inflammation in human chronic heart failureLong-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters alpha 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional levelIsosorbide 5-mononitrate reverses high blood pressure in NG-nitro-L-arginine methyl ester treated rats
P50
Q34115247-D1434C3F-6675-4D7B-B732-DCE3845CF66DQ35129956-91C2476C-7521-4BB4-9CDC-DD0446541601Q37564150-3DB26832-2CCF-4754-BC96-13DCFDEE72E4Q38690530-16038F6E-1961-4BF9-B739-015D92B41340Q38695806-D4224FDB-B685-44B0-8E5A-6A6049DEA0E3Q38740569-81ED1B73-847C-4079-8F09-AA479C9883DDQ39844488-3773B499-931D-4148-9D07-5962E90A495EQ40358428-019818D8-AFBE-4345-8336-1E11A2134AECQ41146478-1C84B2F0-9E8D-458A-B966-251994C9C0CFQ41194577-F2441E56-70BA-4878-A4BC-86BA2249FEE5Q41202467-79B2E764-A053-409A-9B22-FDBD3F2FA64CQ41288115-CE897259-4AEF-46B5-B7BD-FAC5889912B1Q41456019-EEA22B3C-3AAF-49EA-8B33-BFBD747C02F7Q42209812-6D607372-9288-4FB6-B84D-EBEF5A6D280FQ42370170-21F9EE18-F7ED-405E-88E0-730B41718918Q43155701-AE463342-C90E-40FB-A6C1-37AFA865DC0FQ44010393-7BC164E3-7C05-483E-ABB7-13E67513BC21Q44940405-2212FD73-B2A6-453D-8315-CF0E73C6B29AQ45078606-152D6AB0-8600-4FB8-8440-20659FBA3598Q46179273-6478BA28-72BF-42B5-8144-8929F18F36F4Q46419822-F702DE79-868A-4C8A-B795-B55DE6FF29CAQ46507693-09A4D030-65B8-4A19-90C8-FEC8CB109EFEQ46562981-CA23814E-009D-45FB-BADC-71A9195B2F67Q46889855-4379DFCD-A1F7-44A6-AF76-3A030E7FCD66Q46913143-580EF392-3936-455F-95AA-01FDAA999F56Q46924055-5721F97B-C576-4747-B77E-A602FF095C66Q46927088-35872B6D-EACA-42B6-A382-C7EC2B5C0810Q48878707-AEB61224-139A-4AC9-A770-FAB461263026Q50801294-7FDBCE1B-207F-4E49-A413-36EC8B9000B3Q60681752-41D384CA-6260-4A07-A5A4-66F4190C28BEQ61460417-3889B2CA-A400-4EE5-B500-984CC28DBC37Q63434116-6FDF76BF-D18B-4837-AFA0-0EB5D34FFE01Q63434120-A7EBEB7B-B56E-47FD-94BB-4A70E1F8A9A5Q72136359-F2A00BFC-6D40-47F8-AE10-0612B154F830Q72643952-A8DB9746-E261-499A-ACB5-F2C4FFDDF8F1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
António Albino-Teixeira
@ast
António Albino-Teixeira
@en
António Albino-Teixeira
@es
António Albino-Teixeira
@nl
António Albino-Teixeira
@sl
type
label
António Albino-Teixeira
@ast
António Albino-Teixeira
@en
António Albino-Teixeira
@es
António Albino-Teixeira
@nl
António Albino-Teixeira
@sl
prefLabel
António Albino-Teixeira
@ast
António Albino-Teixeira
@en
António Albino-Teixeira
@es
António Albino-Teixeira
@nl
António Albino-Teixeira
@sl
P106
P1153
6701403966
P21
P31
P496
0000-0003-0097-2953